Samantha McLemore Patient Capital Management
Samantha McLemore is the founder of Patient Capital Management and previously worked closely with Bill Miller on value-oriented strategies. Her firm emphasizes long-term, research-driven equity investing with a willingness to hold unconventional or out-of-favor ideas. McLemore’s portfolio is followed by investors who track the next generation of independent value managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$29.7M |
| 2 |
Kosmos Energy
KOS
|
+$29.3M |
| 3 |
Biogen
BIIB
|
+$26.7M |
| 4 |
Seadrill
SDRL
|
+$25.2M |
| 5 |
Royalty Pharma
RPRX
|
+$22.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Travel + Leisure Co
TNL
|
+$38.9M |
| 2 |
Expedia Group
EXPE
|
+$35.3M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$25.1M |
| 4 |
United Airlines
UAL
|
+$23.7M |
| 5 |
SoFi Technologies
SOFI
|
+$20.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 27.73% |
| 2 | Financials | 16.69% |
| 3 | Communication Services | 14.9% |
| 4 | Healthcare | 12.55% |
| 5 | Industrials | 11.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Crocs
CROX
$5.85B
| $48.8M | 2.25% |
445,227
+64,258
| +17% | +$7.48M |
|
27
Mattel
MAT
$4.15B
| $44.9M | 2.07% |
2,532,472
-4,173
| -0.2% | -$78.9K |
|
|
GOOS
28
Canada Goose Holdings
GOOS
$854M
| $38.7M | 1.78% |
3,854,520
+128,133
| +3% | +$1.31M |
|
29
Peloton Interactive
PTON
$2.37B
| $33.2M | 1.53% |
3,817,374
-1,237,958
| -24% | -$9.65M |
|
30
Fidelity Wise Origin Bitcoin Fund
FBTC
$14.3B
| $24.9M | 1.15% |
305,603
+208,752
| +216% | +$15.1M |
|
|
EXE
31
Expand Energy Corp
EXE
$22.2B
| $23.6M | 1.09% |
236,911
+227
| +0.1% | +$21K |
|
32
Precigen
PGEN
$2.58B
| $20M | 0.92% |
17,881,246
-56,448
| -0.3% | -$48.1K |
|
33
JPMorgan Chase
JPM
$935B
| $7.04M | 0.33% |
29,386
| – | – |
|
|
34
Travel + Leisure Co
TNL
$4.39B
| $5.88M | 0.27% |
116,599
-767,534
| -87% | -$38.9M |
|
|
EVRI
35
DELISTED
Everi Holdings
EVRI
| $4.06M | 0.19% |
300,310
-62,310
| -17% | -$833K |
|
36
JD.com
JD
$39.7B
| $3.47M | 0.16% |
+100,000
| New | +$3.87M |
|
37
Western Alliance Bancorporation
WAL
$8.69B
| $2.36M | 0.11% |
28,282
-207,210
| -88% | -$18.2M |
|
38
Teva Pharmaceuticals
TEVA
$43.5B
| $2.2M | 0.1% |
100,000
| – | – |
|
|
FISV
39
Fiserv Inc
FISV
$28B
| $2.06M | 0.1% |
10,042
-122,828
| -92% | -$25.1M |
|
40
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $2.03M | 0.09% |
3,463
+1,977
| +133% | +$1.16M |
|
41
Lennar Class B
LEN.B
$20.6B
| $1.65M | 0.08% |
13,150
| – | – |
|
42
APA Corp
APA
$15.2B
| $1.15M | 0.05% |
+50,000
| New | +$1.17M |
|
43
Brilliant Earth
BRLT
$22.5M
| $210K | 0.01% |
100,000
-141,445
| -59% | -$260K |
|
Similar funds
Samantha McLemore's Q4 2024 Portfolio in Review
As of Q4 2024, Samantha McLemore held 43 positions worth $2.17B, up 6.4% from $2.04B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 4.7%. Samantha McLemore opened 2 new positions and made no exits, leaving the 43-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 31% a quarter earlier, followed by Financials and Communication Services.
- Samantha McLemore's largest Q4 2024 buy was JD.com: 100,000 shares worth $3.47M.
- Samantha McLemore added most to CVS Health in Q4 2024, an estimated $29.7M increase.
- Samantha McLemore's biggest Q4 2024 reduction was Travel + Leisure Co, cutting an estimated $38.9M.
- Samantha McLemore's ten largest holdings make up 45% of its $2.17B portfolio in Q4 2024.
- Samantha McLemore opened 2 new positions and closed 0 in Q4 2024.
- Samantha McLemore's portfolio value rose 6.4% quarter-over-quarter to $2.17B.
Based on Patient Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.